Stem, Inc. $STEM reported third-quarter 2026 revenue of $36.7 million, below the $41.1 million estimate. Revenue was down 4.1% from a year ago, while gross profit rose 23.5% to $16.8 million, showing improved profitability at the gross level.
The company posted an operating loss of $6.8 million and a net loss attributable to common shareholders of $14.6 million. Diluted earnings per share came in at -$1.51, narrower than expected on an absolute basis versus the loss outlook, but still negative.
Cash flow weakened sharply, with operating cash flow of $1.5 million and capital spending of $6.6 million. Stem ended the quarter with $37.0 million in cash and cash equivalents and $533.7 million in total liabilities.
Key points from the release:
- Revenue missed Wall Street expectations
- Gross profit increased despite lower sales
- Operating and net losses remained substantial
- Cash generation was limited during the quarter
- The stock fell 17.1% after the report
Note: This financials data is sourced from a third-party provider and has not been independently verified by Quiver.
Stem, Inc. Insider Trading Activity
Stem, Inc. insiders have traded $STEM stock on the open market 6 times in the past 6 months. Of those trades, 0 have been purchases and 6 have been sales.
Here’s a breakdown of recent trading of $STEM stock by insiders over the last 6 months:
- ARUN NARAYANAN (Chief Executive Officer) sold 1,996 shares for an estimated $15,668
- MICHAEL JAMES CARLSON (President, Managed Services) has made 0 purchases and 2 sales selling 1,493 shares for an estimated $11,255.
- MATTHEW TAPPIN (President, Software Products) sold 996 shares for an estimated $7,818
- BRIAN MUSFELDT (Chief Financial Officer) sold 996 shares for an estimated $6,085
- SAUL R. LAURELES (Chief Legal Officer) sold 675 shares for an estimated $5,298
To track insider transactions, check out Quiver Quantitative's insider trading dashboard. You can access data on insider stock transactions through the Quiver Quantitative API insider transaction endpoint.
Stem, Inc. Hedge Fund Activity
We have seen 26 institutional investors add shares of Stem, Inc. stock to their portfolio, and 38 decrease their positions in their most recent quarter.
Here are some of the largest recent moves:
- MARSHALL WACE, LLP removed 171,573 shares (-42.3%) from their portfolio in Q3 2026, for an estimated $729,185
- ACADIAN ASSET MANAGEMENT LLC added 103,062 shares (+138.1%) to their portfolio in Q3 2026, for an estimated $438,013
- GSA CAPITAL PARTNERS LLP removed 102,321 shares (-100.0%) from their portfolio in Q3 2026, for an estimated $434,864
- TWO SIGMA INVESTMENTS, LP removed 91,598 shares (-88.7%) from their portfolio in Q3 2026, for an estimated $389,291
- LONGAEVA PARTNERS L.P. added 48,186 shares (+inf%) to their portfolio in Q2 2026, for an estimated $376,332
- BRIDGEWAY CAPITAL MANAGEMENT, LLC removed 44,259 shares (-74.3%) from their portfolio in Q3 2026, for an estimated $188,100
- MORGAN STANLEY added 40,791 shares (+108.3%) to their portfolio in Q3 2026, for an estimated $173,361
To track hedge funds' stock portfolios, check out Quiver Quantitative's institutional holdings dashboard. You can access data on hedge funds moves and 13F filings through the Quiver Quantitative API 13F endpoint.
Stem, Inc. Analyst Ratings
Wall Street analysts have issued reports on $STEM in the last several months. We have seen 1 firms issue buy ratings on the stock, and 0 firms issue sell ratings.
Here are some recent analyst ratings:
- UBS issued a "Buy" rating on 09/25/2026
To track analyst ratings and price targets for Stem, Inc., check out Quiver Quantitative's $STEM forecast page.
Stem, Inc. Price Targets
Multiple analysts have issued price targets for $STEM recently. We have seen 4 analysts offer price targets for $STEM in the last 6 months, with a median target of $6.0.
Here are some recent targets:
- Ameet Thakkar from BMO Capital set a target price of $5.0 on 10/21/2026
- Biju Perincheril from Susquehanna set a target price of $4.5 on 10/14/2026
- Jon Windham from UBS set a target price of $7.0 on 09/25/2026
- Christine Cho from Barclays set a target price of $8.0 on 07/27/2026